Provided by Tiger Trade Technology Pte. Ltd.

Maze Therapeutics

26.43
-0.2200-0.83%
Post-market: 26.430.00000.00%19:30 EDT
Volume:633.05K
Turnover:16.89M
Market Cap:1.46B
PE:-10.50
High:27.49
Open:27.08
Low:26.36
Close:26.65
52wk High:53.65
52wk Low:21.95
Shares:55.25M
Float Shares:37.25M
Volume Ratio:0.81
T/O Rate:1.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5172
EPS(LYR):-3.0510
ROE:-37.35%
ROA:-21.79%
PB:3.22
PE(LYR):-8.66

Loading ...

Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 17, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Oct 06, 2025

Major Issues Report

Form 8-K - Current report
Sep 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 11, 2025

Major Issues Report

Form 8-K - Current report
Sep 02, 2025

Major Issues Report

Form 8-K - Current report
Aug 12, 2025

Major Issues Report

Form 8-K - Current report
Aug 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2025

Major Issues Report

Form 8-K - Current report
Mar 31, 2025

Major Issues Report

Form 8-K - Current report
Mar 31, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 31, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 30, 2025

Correspondence

Form CORRESP - Correspondence
Jan 30, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 29, 2025

Correspondence

Form CORRESP - Correspondence
Jan 29, 2025

Correspondence

Form CORRESP - Correspondence
Jan 27, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 22, 2025

Correspondence

Form CORRESP - Correspondence
Jan 10, 2025

Correspondence

Form CORRESP - Correspondence